Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Wang (Beijing , China), X. Zhang (Beijing , China). IFN? involvement in adipogenesis of OSA patients. 1336

Member's Comments

No comment yet.

Related content which might interest you: Reduced expression of interferon stimulated genes in refractory asthma Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012 The role of obesity in patients with sarcoidosis Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 Interleukin-17 cytokine signalling in patients with asthma Source: Eur Respir J 2014; 44: 1319-1331 Year: 2014 Differential regulation of cytokine production is mediated by IL-17 in obese children with obstructive sleep apnoea Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Interferon gamma (IFN?) pathway deficiency and severe NTM disease Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021 Is OSA an important risk factor for metabolic dysregulation in obese COPD patients Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 Does APAP-therapy induce central apneas in OSAS patients? Source: Eur Respir J 2005; 26: Suppl. 49, 725s Year: 2005 Does diabetes mellitus affect T-cell interferon-gamma responses in TB patients? Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 Increased CTGF expression of circulating fibrocytes in asthmatic patients with severe OSA - the role of HIF-1a and HDAC7 Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 Is OSAS a systemic disease? Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007 In-vivo and in-vitro production of interferon gamma in pediatric patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 140s Year: 2002 Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006 TLR7/8 regulates type I and type III interferon signalling in rhinovirus 1b-induced allergic asthma Source: Eur Respir J, 57 (5) 2001562; 10.1183/13993003.01562-2020 Year: 2021 Antiviral biomarkers are upregulated in sputum cells following administration of inhaled interferon beta to COPD patients Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 Increased interferon and decreased NRF2-PPARG signaling is associated with frequent exacerbations in COPD Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 R667 retinoid agonist modulates blood glucose in COPDe patients with improved metabolic profile compared to ATRA Source: Annual Congress 2007 - New drugs for COPD Year: 2007 Is classical OSA the same as OSA in other diseases ? Source: 5th Sleep and Breathing Conference Year: 2019 The involvement of thrombospondin-1 in COPD pathogenesis through IL-8 production Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Mild OSAS: Is CPAP therapy actually required for these patients? Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018